Viewing StudyNCT05155566



Ignite Creation Date: 2024-05-06 @ 4:59 PM
Last Modification Date: 2024-10-26 @ 2:20 PM
Study NCT ID: NCT05155566
Status: COMPLETED
Last Update Posted: 2024-01-26
First Post: 2021-12-09

Brief Title: Treatment Patterns And Clinical Outcomes Among Patients in Latin America Receiving First Line Palbociclib Combinations For HRHER2- AdvancedMetastatic Breast Cancer In Real World Settings
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-05-15
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-12
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-12
Completion Date Type: ACTUAL
First Submit Date: 2021-12-09
First Submit QC Date: December 9 2021
Study First Post Date: 2021-12-13
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2024-01-26
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-05-15
Last Update Post Date: 2024-01-26
Last Update Post Date Type: ACTUAL